Welcome to LookChem.com Sign In|Join Free

CAS

  • or

948-03-8

Post Buying Request

948-03-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

948-03-8 Usage

Uses

Methyl 1-hydroxy-2-naphthoate may be used as a starting reagent for the synthesis of axially chiral benzimidazole derivatives.It may also be employed in the synthesis of the following aza-mollugin derivatives: azamollugin2-desmethyl-azamollugin 2,2-didesmethyl-azamollugin

General Description

The asymmetric unit of the crystal of methyl 1-hydroxy-2-naphthoate contains two independent planar molecules that exhibit intra-molecular hydrogen bonds. Methyl 1-hydroxy-2-naphthoate can be prepared from 1-hydroxy-2-naphthoic acid, via esterification.

Check Digit Verification of cas no

The CAS Registry Mumber 948-03-8 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 9,4 and 8 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 948-03:
(5*9)+(4*4)+(3*8)+(2*0)+(1*3)=88
88 % 10 = 8
So 948-03-8 is a valid CAS Registry Number.
InChI:InChI=1/C12H10O3/c1-15-12(14)10-7-6-8-4-2-3-5-9(8)11(10)13/h2-7,13H,1H3

948-03-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name METHYL 1-HYDROXY-2-NAPHTHOATE

1.2 Other means of identification

Product number -
Other names methyl 1-hydroxynaphthalene-2-carboxylate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:948-03-8 SDS

948-03-8Relevant articles and documents

Structural insight into the anion-water cluster: Stabilised by alcohol and carboxylic acid containing tripodal ligand

Hoque, Md. Najbul,Basu, Arghya,Das, Gopal

, p. 392 - 402 (2014)

A new flexible N-bridged, unsymmetrical, water-soluble tripodal ligand (L) bearing alcohol and carboxylic acid groups has been synthesised and its solid-state interaction with anions has been investigated. The fully deprotonated ligand encapsulates a sodium cation in a half cryptand bowl-shaped cavity (1). The chloride complex 2, contains a cyclohexane-like water cluster incorporating ligand OH groups. However, complexes with bromide and nitrate (3 and 4) are dimeric. Tetrahedral clusters containing two water molecules and two anions were found in complexes 3 and 4. Perchlorate complex 5 forms perchlorate-methanol adducts. Complex 1 forms a hydrophilic cation-water channel and complexes 2-4 form anion-water channels between the hydrophobic layers of the naphthalene moieties. Complexes 2, 5 and 3, 4 are isostructural in nature having similar packing structures.

Fluorescence turn on sensor for sulfate ion in aqueous medium using tripodal-Cu2+ ensemble

Hoque, Md. Najbul,Basu, Arghya,Das, Gopal

, p. 411 - 416 (2014)

We report the selective recognition of sulfate anion in aqueous medium at biological pH 7.2 over the other interfering anions based on naphthoic acid bearing tripodal ligand by applying fluorescence turn off-on mechanism. The carboxylic acid groups in the ligand enhance the solubility in water and enable it to form complex with copper salt. Thus formed L-Cu2+ ensemble quench the fluorescence of the parent ligand and in turn recognize sulfate anion via revival of fluorescence intensity. The 1:2 stoichiometry was confirmed by ESI mass spectral data and Job's plot. The average binding constant was found to be 6.2∈×∈108 M-2. [Figure not available: see fulltext.]

CFTR-MODULATING ARYLAMIDES

-

Page/Page column 69; 70; 71, (2021/06/11)

The present disclosure relates to heterocyclic compounds, pharmaceutically acceptable salts thereof, and pharmaceutical preparations thereof. Also described herein are compositions and the use of such compounds in methods of treating diseases and conditions mediated by deficient CFTR activity, in particular cystic fibrosis.

Condensed fluorene derivative comprising heterocyclic ring

-

Paragraph 0529-0535, (2019/12/25)

The present invention relates to a condensed fluorene derivative comprising a heterocyclic ring and, more particularly, to an intermediate product for manufacturing a heterocyclic ring compound which can show excellent luminance and luminous efficiency when used as an organic light emitting material, while exhibiting excellent element characteristics with a long lifespan.COPYRIGHT KIPO 2020

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 948-03-8